NUTX logo

Nutex Health Inc. (NUTX)

$206.15

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NUTX

Market cap

$1.41B

EPS

26.77

P/E ratio

7.7

Price to sales

1.67

Dividend yield

--

Beta

2.002901

Price on NUTX

Previous close

$206.29

Today's open

$206.18

Day's range

$198.56 - $212

52 week range

$83.99 - $226.16

Profile about NUTX

CEO

Thomas T. Vo

Employees

800

Headquarters

Houston, TX

Exchange

NASDAQ Capital Market

Shares outstanding

6847973

Issue type

Common Stock

NUTX industries and sectors

Healthcare

Healthcare Providers & Services

News on NUTX

Top Healthcare Stocks: Playing Offense And Defense For The Win

Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.

news source

Seeking Alpha • a day ago

news preview

5 Stocks With Recent Price Strength After a Mixed September

Five stocks showing recent price strength include VNCE, VRA, AOUT, NUTX and FET, with strong momentum and improving earnings estimates.

news source

Zacks Investment Research • Oct 5, 2026

news preview

Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns

Let's take a look at four stocks, NUTX, RCMT, TILE and QUAD, with impressive net profit margins for a robust portfolio.

news source

Zacks Investment Research • Oct 1, 2026

news preview

Nutex Health: A High-Risk, High-Reward Play For Speculative Investors

Nutex Health has surged 134% since April, driven by its out-of-network micro-hospital model and expanding margins. It has staged a turnaround in 2026, driven by strong EPS growth after years of struggle. The company leverages the No Surprises Act's arbitration process to sustain margins against insurer underpayment, making dispute resolution central to its current business.

news source

Seeking Alpha • Sep 26, 2026

news preview

Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)

Nutex Health is rated Strong Buy, with a new target price of $290.43, representing 39.1% upside from current levels. NUTX's profitability and growth metrics significantly outpace peers, driven by effective use of the No Surprises Act and disciplined cost controls. Consensus EPS projections for FY2026 and FY2027 have materially increased, with FY2026 EPS now expected at $27.79, supporting a forward PE of just 10.5.

news source

Seeking Alpha • Sep 24, 2026

news preview

Nutex Health Approved for Dual Listing on Nasdaq Texas

HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) today announced that it has received approval to dual-list its common stock on Nasdaq Texas.

news source

PRNewsWire • Sep 22, 2026

news preview

5 Stocks With Recent Price Strength Amid a Volatile September

EDRY, VNCE, NUTX, TXO and KB show strong recent price momentum despite a volatile September, backed by improving earnings expectations.

news source

Zacks Investment Research • Sep 17, 2026

news preview

What Makes Nutex Health (NUTX) a Good Fit for 'Trend Investing'

Nutex Health (NUTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

news source

Zacks Investment Research • Sep 11, 2026

news preview

NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT

HOUSTON, Sept. 10, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today provided an update regarding its previously announced cybersecurity event.

news source

PRNewsWire • Sep 10, 2026

news preview

Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data

Free case evaluations for individuals affected by the Nutex Health cyberattack claimed by The Gentlemen ransomware group HOUSTON, Sept. 1, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a cyberattack on Nutex Health Inc. (NASDAQ: NUTX).

news source

PRNewsWire • Sep 2, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Nutex Health Inc.

Open an M1 investment account to buy and sell Nutex Health Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NUTX on M1